| Followers | 74 |
| Posts | 7304 |
| Boards Moderated | 0 |
| Alias Born | 09/09/2009 |
Thursday, February 10, 2022 12:55:51 PM
What sticks out to me is the the partnership info, if they are selling 50% stake that could be worth tens of millions if not hundreds over whatever length of time its structured at. Plus if a major pharmaceutical company is taking over sales and marketing it will grow faster then a new company like ALRT trying to sell it on their own. If they resume talks in march I would think a deal could be finalized and announced as soon as April or maybe May. Either way, the finish lines is quickly approaching
Recent ALRTF News
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2026 09:06:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 04:57:15 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/05/2026 06:15:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/30/2025 06:49:39 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/30/2025 06:38:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/07/2025 09:10:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/26/2025 05:31:37 PM
- Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 05/02/2025 05:45:54 PM
